Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Particle replication in nonwetting templates nanoparticles with tumor selective alkyl silyl ether docetaxel prodrug reduces toxicity.

Chu KS, Finniss MC, Schorzman AN, Kuijer JL, Luft JC, Bowerman CJ, Napier ME, Haroon ZA, Zamboni WC, DeSimone JM.

Nano Lett. 2014 Mar 12;14(3):1472-6. doi: 10.1021/nl4046558. Epub 2014 Feb 24.

2.

Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles.

Hwang HY, Kim IS, Kwon IC, Kim YH.

J Control Release. 2008 May 22;128(1):23-31. doi: 10.1016/j.jconrel.2008.02.003. Epub 2008 Feb 20.

PMID:
18374444
3.

Development of a weak-base docetaxel derivative that can be loaded into lipid nanoparticles.

Zhigaltsev IV, Winters G, Srinivasulu M, Crawford J, Wong M, Amankwa L, Waterhouse D, Masin D, Webb M, Harasym N, Heller L, Bally MB, Ciufolini MA, Cullis PR, Maurer N.

J Control Release. 2010 Jun 15;144(3):332-40. doi: 10.1016/j.jconrel.2010.02.029. Epub 2010 Mar 2.

PMID:
20202473
4.

Multifunctional tumor-targeting nanocarriers based on hyaluronic acid-mediated and pH-sensitive properties for efficient delivery of docetaxel.

Song S, Chen F, Qi H, Li F, Xin T, Xu J, Ye T, Sheng N, Yang X, Pan W.

Pharm Res. 2014 Apr;31(4):1032-45. doi: 10.1007/s11095-013-1225-y. Epub 2013 Oct 24.

PMID:
24154802
5.

Enhanced tolerance and antitumor efficacy by docetaxel-loaded albumin nanoparticles.

Tang X, Wang G, Shi R, Jiang K, Meng L, Ren H, Wu J, Hu Y.

Drug Deliv. 2016 Oct;23(8):2686-2696. Epub 2015 May 25.

PMID:
26004129
6.

Antitumor efficiency of D-alpha-tocopheryl polyethylene glycol 1000 succinate-b-poly(epsilon-caprolactone-ran-lactide) nanoparticle-based delivery of docetaxel in mice bearing cervical cancer.

Wang Z, Zeng X, Ma Y, Liu J, Tang X, Gao Y, Liu K, Zhang J, Ming P, Huang L, Mei L.

J Biomed Nanotechnol. 2014 Aug;10(8):1509-19.

PMID:
25016651
7.

Preparation, characterization, and antitumor activities of folate-decorated docetaxel-loaded human serum albumin nanoparticles.

Jiang S, Gong X, Zhao X, Zu Y.

Drug Deliv. 2015 Feb;22(2):206-13. doi: 10.3109/10717544.2013.879964. Epub 2014 Jan 29.

PMID:
24471890
8.

Investigation of hydrophobically derivatized hyperbranched polyglycerol with PEGylated shell as a nanocarrier for systemic delivery of chemotherapeutics.

Misri R, Wong NK, Shenoi RA, Lum CM, Chafeeva I, Toth K, Rustum Y, Kizhakkedathu JN, Khan MK.

Nanomedicine. 2015 Oct;11(7):1785-95. doi: 10.1016/j.nano.2015.04.016. Epub 2015 May 14.

PMID:
25981338
9.

The multilayer nanoparticles formed by layer by layer approach for cancer-targeting therapy.

Oh KS, Lee H, Kim JY, Koo EJ, Lee EH, Park JH, Kim SY, Kim K, Kwon IC, Yuk SH.

J Control Release. 2013 Jan 10;165(1):9-15. doi: 10.1016/j.jconrel.2012.10.013. Epub 2012 Oct 24.

PMID:
23103984
10.

Anti-angiogenesis therapy in the Vx2 rabbit cancer model with a lipase-cleavable Sn 2 taxane phospholipid prodrug using α(v)β₃-targeted theranostic nanoparticles.

Pan D, Schmieder AH, Wang K, Yang X, Senpan A, Cui G, Killgore K, Kim B, Allen JS, Zhang H, Caruthers SD, Shen B, Wickline SA, Lanza GM.

Theranostics. 2014 Mar 11;4(6):565-78. doi: 10.7150/thno.7581. eCollection 2014.

11.

Development of docetaxel-loaded solid self-nanoemulsifying drug delivery system (SNEDDS) for enhanced chemotherapeutic effect.

Seo YG, Kim DH, Ramasamy T, Kim JH, Marasini N, Oh YK, Kim DW, Kim JK, Yong CS, Kim JO, Choi HG.

Int J Pharm. 2013 Aug 16;452(1-2):412-20. doi: 10.1016/j.ijpharm.2013.05.034. Epub 2013 May 22.

PMID:
23707964
12.

Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic® for tumor-targeted delivery of docetaxel.

Cho HJ, Yoon HY, Koo H, Ko SH, Shim JS, Lee JH, Kim K, Kwon IC, Kim DD.

Biomaterials. 2011 Oct;32(29):7181-90. doi: 10.1016/j.biomaterials.2011.06.028. Epub 2011 Jul 5.

PMID:
21733572
13.

A comparative study on the effect of docetaxel-albumin nanoparticles and docetaxel-loaded PEG-albumin nanoparticles against non-small cell lung cancer.

Jin G, Jin M, Yin X, Jin Z, Chen L, Gao Z.

Int J Oncol. 2015 Nov;47(5):1945-53. doi: 10.3892/ijo.2015.3174. Epub 2015 Sep 18.

PMID:
26398837
14.

Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.

Fan J, Fang G, Wang X, Zeng F, Xiang Y, Wu S.

Nanotechnology. 2011 Nov 11;22(45):455102. doi: 10.1088/0957-4484/22/45/455102. Epub 2011 Oct 21.

PMID:
22019849
15.

Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides.

Gao W, Xiang B, Meng TT, Liu F, Qi XR.

Biomaterials. 2013 May;34(16):4137-49. doi: 10.1016/j.biomaterials.2013.02.014. Epub 2013 Mar 1.

PMID:
23453200
16.

Gelatin-encapsulated iron oxide nanoparticles for platinum (IV) prodrug delivery, enzyme-stimulated release and MRI.

Cheng Z, Dai Y, Kang X, Li C, Huang S, Lian H, Hou Z, Ma P, Lin J.

Biomaterials. 2014 Aug;35(24):6359-68. doi: 10.1016/j.biomaterials.2014.04.029. Epub 2014 May 9.

PMID:
24816364
17.

Prodrug-based nanoparticulate drug delivery strategies for cancer therapy.

Luo C, Sun J, Sun B, He Z.

Trends Pharmacol Sci. 2014 Nov;35(11):556-66. doi: 10.1016/j.tips.2014.09.008. Epub 2014 Oct 16. Review.

PMID:
25441774
18.

Albumin anchored docetaxel lipid nanoemulsion for improved targeting efficiency - preparation, characterization, cytotoxic, antitumor and in vivo imaging studies.

Muzammil Afzal S, Naidu VG, Harishankar N, Kishan V.

Drug Deliv. 2016 May;23(4):1355-63. doi: 10.3109/10717544.2015.1030715. Epub 2015 May 19.

PMID:
25987186
19.

Incorporation and controlled release of silyl ether prodrugs from PRINT nanoparticles.

Parrott MC, Finniss M, Luft JC, Pandya A, Gullapalli A, Napier ME, DeSimone JM.

J Am Chem Soc. 2012 May 9;134(18):7978-82. doi: 10.1021/ja301710z. Epub 2012 Apr 30.

20.

Lamellar crystalline self-assembly behaviour and solid lipid nanoparticles of a palmityl prodrug analogue of Capecitabine--a chemotherapy agent.

Gong X, Moghaddam MJ, Sagnella SM, Conn CE, Danon SJ, Waddington LJ, Drummond CJ.

Colloids Surf B Biointerfaces. 2011 Jul 1;85(2):349-59. doi: 10.1016/j.colsurfb.2011.03.007. Epub 2011 Mar 11.

PMID:
21477999

Supplemental Content

Support Center